NKTR-255+cetuximab in patients with solid tumors: Interim safety and efficacy results from the phase 1b dose-escalation study Meeting Abstract
| Authors: | Altan, M.; Patnaik, A.; Barve, M.; Dunn, L.; Cobb, P.; Rosenberg, A.; Sharma, S.; Sukari, A.; Patel, M.; Wang, X.; Ma, H.; Dixit, N.; Nieves, W.; Fanton, C.; Currie, S.; Lee, Z.; Marcondes, M.; Zalevsky, J.; Tagliaferri, M.; Sacco, A. |
| Abstract Title: | NKTR-255+cetuximab in patients with solid tumors: Interim safety and efficacy results from the phase 1b dose-escalation study |
| Meeting Title: | 36th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2021) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 9 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2021 Nov 10-14 |
| Meeting Location: | Washington, DC |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2021-11-01 |
| Start Page: | A1007 |
| Language: | English |
| ACCESSION: | WOS:000774877500925 |
| DOI: | 10.1136/jitc-2021-SITC2021.957 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 957 -- Meeting was also held virtually -- Source: Wos |
